Cargando…
Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting Assay: A Prospective, Single-Arm, Open-Label Study
Routine coagulation tests do not enable rapid, accurate determination of direct oral anticoagulant (DOAC) therapy. The ecarin clotting assay (ECA), performed on the ClotPro viscoelastic testing device, may enable sensitive and specific detection of dabigatran. We assessed the association between tro...
Autores principales: | Fong, Alan Yean Yip, Tiong, Lee Len, Tan, Shirley Siang Ning, Geruka, Dominic, Apil, Gerald Grino, Choo, Chee Wei, Ong, Tiong Kiam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724398/ https://www.ncbi.nlm.nih.gov/pubmed/33284050 http://dx.doi.org/10.1177/1076029620972473 |
Ejemplares similares
-
Monitoring the Coagulation Profile of COVID-19 Patients Using Standard and ClotPro(®) Hemostasis Tests
por: Milić, Dragan, et al.
Publicado: (2023) -
Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(®) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients
por: Oberladstätter, Daniel, et al.
Publicado: (2021) -
A comparison of the ClotPro system with rotational thromboelastometry in cardiac surgery: a prospective observational study
por: Yoshii, Ryogo, et al.
Publicado: (2022) -
Is the ecarin clotting time (ECT) a valid monitoring parameter for r-hirudin-based anticoagulation in continuous renal replacement therapy?
por: v Heymann, C, et al.
Publicado: (2000) -
Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19
por: Infanger, Lukas, et al.
Publicado: (2021)